Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
InspireMD, Inc. (NSPR) received an updated ownership report from Rosalind-related investors on an amended Schedule 13G as of 12/31/2025. Rosalind Advisors, Inc., Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P., and portfolio managers Steven Salamon and Gilad Aharon collectively report beneficial ownership of 3,905,743 common shares, or 9.2% of InspireMD’s common stock, based on 42,370,995 shares outstanding as of November 10, 2025.
The group also holds 7,081,361 common shares issuable upon exercise of pre-funded and standard warrants, but these cannot currently be exercised because of a 9.99% “blocker” that prevents exercises which would push holdings above that level. The reporting persons state that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of InspireMD.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in InspireMD (NSPR) do the Rosalind entities report?
Rosalind-related investors report beneficial ownership of 3,905,743 InspireMD common shares, or 9.2% of the company. This percentage is calculated using 42,370,995 common shares outstanding as of November 10, 2025, as disclosed in InspireMD’s Form 10-Q.
Who are the reporting persons in this InspireMD (NSPR) Schedule 13G/A?
The filing lists Rosalind Advisors, Inc., Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P., Steven Salamon, and Gilad Aharon as reporting persons. Rosalind Advisors acts as investment advisor to the funds, with Salamon and Aharon serving as portfolio managers associated with the advisor.
How many InspireMD (NSPR) warrants do the Rosalind investors hold?
The group references 7,081,361 InspireMD common shares issuable upon exercise of pre-funded and standard warrants. These potential shares are subject to a 9.99% blocker, which currently prevents warrant exercises that would push their beneficial ownership above that threshold.
What is the blocker provision affecting InspireMD (NSPR) warrants held by Rosalind?
The warrants contain a 9.99% “blocker” limiting how many shares can be acquired upon exercise. The holders cannot exercise any warrants if doing so would result in beneficial ownership above 9.99% of InspireMD’s outstanding common stock, effectively capping their exercisable position.
Are the Rosalind investors seeking control of InspireMD (NSPR) with this stake?
The reporting persons state the securities were acquired and are held in the ordinary course of business. They certify that the holdings are not for the purpose of changing or influencing control of InspireMD and are not part of any control-related transaction.
How is beneficial ownership in InspireMD (NSPR) allocated among the Rosalind funds?
Rosalind Master Fund L.P. reports 8.3% of the class and Rosalind Opportunities Fund I L.P. reports 1.0%. Rosalind Advisors, Inc., and portfolio managers Steven Salamon and Gilad Aharon may be deemed to share beneficial ownership through their advisory and management roles.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 9)
InspireMD, Inc.
(Name of Issuer)
Common Shares
(Title of Class of Securities)
45779A846
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
45779A846
1
Names of Reporting Persons
Rosalind Advisors, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
ONTARIO, CANADA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
10,987,104.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
10,987,104.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
10,987,104.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.2 %
12
Type of Reporting Person (See Instructions)
CO
Comment for Type of Reporting Person: The percentage set forth in Row 11 of the cover page for each Reporting Person is based upon 42,370,995 shares of common stock outstanding of the Issuer as of November 10, 2025, in accordance with the 10Q filed on November 10th. However, as more fully described in Item 4, the securities reported in rows 6, 8, and 9 show the number of shares of Common Stock that would be issuable upon exercise of such reported securities and do not give effect to blocker provisions. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8, and 9.
(6) 3,905,743 shares of Common Stock
7,081,361 shares of Common Stock issuable upon exercise of warrants
SCHEDULE 13G
CUSIP No.
45779A846
1
Names of Reporting Persons
SALAMON STEVEN A J
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
ONTARIO, CANADA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
10,987,104.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
10,987,104.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
10,987,104.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.2 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: (6)3,905,743 shares of Common Stock
7,081,361 shares of Common Stock issuable upon exercise of warrants
SCHEDULE 13G
CUSIP No.
45779A846
1
Names of Reporting Persons
Aharon Gil
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
ONTARIO, CANADA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
10,987,104.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
10,987,104.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
10,987,104.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.2 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: (6)3,905,743 shares of Common Stock
7,081,361 shares of Common Stock issuable upon exercise of warrants
SCHEDULE 13G
CUSIP No.
45779A846
1
Names of Reporting Persons
Rosalind Master Fund L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
9,485,697.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
9,485,697.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
9,485,697.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.3 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: (6)3,508,336 shares of Common Stock
5,977,361 shares of Common Stock issuable upon exercise of warrants
SCHEDULE 13G
CUSIP No.
45779A846
1
Names of Reporting Persons
Rosalind Opportunities Fund I L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
ONTARIO, CANADA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,501,407.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,501,407.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,501,407.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.0 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: (6)397,407 shares of Common Stock
1,104,000 shares of Common Stock issuable upon exercise of warrants
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
InspireMD, Inc.
(b)
Address of issuer's principal executive offices:
6303 WATERFORD DISTRICT DRIVE, 6303 WATERFORD DISTRICT DRIVE, MIAMI, FLORIDA, 33126
Item 2.
(a)
Name of person filing:
Rosalind Advisors, Inc. (Advisor to RMF and ROFI)
Rosalind Master Fund L.P. (RMF)
Rosalind Opportunities Fund I L.P. (ROFI)
Steven Salamon (President)
Steven Salamon is the portfolio manager of the Advisor which advises RMF.
Gilad Aharon is the portfolio manager and member of the Advisor which advises RMF.
(b)
Address or principal business office or, if none, residence:
Rosalind Advisors, Inc.
Rosalind Opportunities Fund I L.P.
15 Wellesley Street West
Suite 326
Toronto, Ontario
M4Y 0G7 Canada
Rosalind Master Fund L.P.
P.O. Box 309
Ugland House, Grand Cayman
KY1-1104, Cayman Islands
Steven Salamon
15 Wellesley Street West
Suite 326
Toronto, Ontario
M4Y 0G7 Canada
Gilad Aharon
15 Wellesley Street West
Suite 326
Toronto, Ontario
M4Y 0G7 Canada
(c)
Citizenship:
Mr. Salamon and Mr. Aharon are citizens of Canada, resident in Ontario
(d)
Title of class of securities:
Common Shares
(e)
CUSIP No.:
45779A846
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information as of the date of the event which requires filing of this statement required by Items 5(a) to (c) is set forth in Rows 7 to 13 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentage set forth in Row 13 of the cover page for each Reporting Person is based upon 42,3760,995 shares of common stock outstanding of the Issuer as of November 10, 2025, in accordance with the 10-Q filed on November 10th.
Rosalind Master Fund L.P.& Rosalind Opportunities Fund I L.P. may have been deemed to have the beneficial ownership of 3,905,743 shares of common stock representing the beneficial ownership of approximately 9.2% of the common stocks as mentioned above, which excludes the 7,081,361 shares issuable upon the exercise of pre-funded and standard warrants because they contain a blocker provision under which the holder thereof does not have the right to exercise any of the warrant to the extent that such exercise would result in beneficial ownership by the holder in excess of 9.99% of the Common Stock. Consequently, as of the date of the event which requires the filing of this statement, the Reporting Persons were not able to exercise any of the warrants due to the Blockers.
Rosalind Advisors, Inc., or the Advisor, is the investment advisor to RMF and ROFI, and may be deemed to be the beneficial owner of shares held by RMF and ROFI. Steven Salamon is the portfolio manager of the Advisor and may be deemed to be the beneficial owner of shares held by RMF and ROFI. Notwithstanding the foregoing, the Advisor and Mr. Salamon disclaim beneficial ownership of the shares.
(b)
Percent of class:
Rosalind Advisors, Inc. 9.2%
Rosalind Master Fund L.P. 8.3%
Rosalind Opportunities Fund I L.P. 1.0%
Steven Salamon 9.2%
Gilad Aharon 9.2%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
Rosalind Advisors, Inc. 3,905,743
Rosalind Master Fund L.P. 3,508,336
Rosalind Opportunities Fund I L.P. 397,407
Steven Salamon 3,905,743
Gilad Aharon - 3,905,743
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
Rosalind Advisors, Inc. 3,905,743
Rosalind Master Fund L.P. 3,508,336
Rosalind Opportunities Fund I L.P. 397,407
Steven Salamon 3,905,743
Gilad Aharon - 3,905,743
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Rosalind Advisors, Inc.
Signature:
Steven Salamon
Name/Title:
President
Date:
02/11/2026
SALAMON STEVEN A J
Signature:
Steven Salamon
Name/Title:
Steven Salamon
Date:
02/11/2026
Aharon Gil
Signature:
GIl Aharon
Name/Title:
Gil Aharon
Date:
02/11/2026
Rosalind Master Fund L.P.
Signature:
Mike McDonald
Name/Title:
Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:
02/11/2026
Rosalind Opportunities Fund I L.P.
Signature:
Steven Salamon
Name/Title:
Director, Rosalind Opportunities Fund I GP. Inc. (as General Partners to Rosalind Opportunities Fund I)
